Financial Performance - Operating revenue for the reporting period was ¥702,588,359.42, down 40.68% year-on-year[7]. - Net profit attributable to shareholders was a loss of ¥103,791,299.92, a decrease of 2,371.40% compared to the same period last year[7]. - Basic earnings per share were -¥0.13, a decrease of 1,400.00% compared to the same period last year[7]. - The total comprehensive income attributable to the parent company decreased by 1,272.82% year-on-year due to losses in the chemical fiber business[17]. - The company reported a net loss of ¥432,053,822.28 for the year-to-date period, compared to a net profit of ¥2,902,750.12 in the same period last year[44]. - The net profit for Q3 2019 was -8,217,453.53 CNY, a significant decline compared to a net profit of 44,246,629.30 CNY in the same period last year[48]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥6,898,038,754.42, an increase of 5.80% compared to the end of the previous year[7]. - The company's total liabilities reached CNY 5,334,894,189.42, compared to CNY 4,496,843,464.54 at the end of 2018, marking an increase of about 18.5%[29]. - The total equity attributable to shareholders decreased to CNY 1,543,932,362.47 from CNY 1,868,592,334.59, a decline of approximately 17.4%[30]. - The company's current assets totaled CNY 2,724,340,456.93, up from CNY 2,556,652,456.41 at the end of 2018, indicating a growth of approximately 6.56%[28]. - Total liabilities rose to ¥2,680,735,148.84, an increase of 44.5% from ¥1,853,880,251.33 in the previous year[35]. Cash Flow - The net cash flow from operating activities was ¥43,673,525.93, an increase of 109.55% year-on-year[7]. - Cash flow from operating activities generated a net cash inflow of 105,192,074.03 CNY, a recovery from a net outflow of -931,244,986.42 CNY in the previous year[52]. - Total cash inflow from operating activities was 2,371,959,384.11 CNY, compared to 2,082,034,853.12 CNY in the same period last year[52]. - The company reported a cash flow from investing activities net outflow of -682,356,508.11 CNY, worsening from -260,253,797.57 CNY in the previous year[53]. - Cash outflow for operating activities was ¥2,024,499,599.03, slightly lower than ¥2,073,090,082.28 in Q3 2018[56]. Shareholder Information - The total number of shareholders at the end of the reporting period was 46,498[11]. - The largest shareholder, Aoyang Group Co., Ltd., held 39.30% of the shares, amounting to 305,154,786 shares[11]. Inventory and Receivables - Inventory decreased by 34.81% compared to the beginning of the period due to the shutdown of some chemical fiber production lines[15]. - Accounts receivable interest grew by 192.5% compared to the beginning of the period due to an increase in unpaid deposit interest income[15]. - The inventory level dropped significantly to CNY 457,727,115.98 from CNY 702,174,916.34, indicating a decrease of about 34.7%[27]. Expenses - Management expenses increased by 97.87% year-on-year due to increased losses from the shutdown of some chemical fiber production lines[15]. - Research and development expenses decreased significantly to ¥610,504.58 from ¥8,835,990.15 year-on-year, a drop of 93%[37]. - The company experienced a significant increase in financial expenses, totaling ¥78,234,009.03 for the year-to-date period, compared to ¥54,401,872.98 in the previous year[42]. Other Financial Metrics - The weighted average return on net assets was -5.71%, compared to -5.95% in the previous year[7]. - The company reported non-recurring gains and losses totaling ¥5,422,596.81 for the year-to-date[8]. - The company incurred a loss of 88,793,845.18 yuan during the shutdown period of the production line[16].
澳洋健康(002172) - 2019 Q3 - 季度财报